AAAAAA
Results: 1-25/67
TRANSGENIC MODELS AND SUBCELLULAR PATHOLOGY - DO THEY TELL US WHAT GOES WRONG IN HUNTINGTONS-DISEASE
Authors:
REYNOLDS GP
DALTON CF
Citation: Gp. Reynolds et Cf. Dalton, TRANSGENIC MODELS AND SUBCELLULAR PATHOLOGY - DO THEY TELL US WHAT GOES WRONG IN HUNTINGTONS-DISEASE, Molecular psychiatry, 3(3), 1998, pp. 192-195
Authors:
REYNOLDS GP
Citation: Gp. Reynolds, RECEPTOR MECHANISMS OF ANTIPSYCHOTIC DRUG ATYPICALITY, European psychiatry, 13, 1998, pp. 5-8
Authors:
BEASLEY CL
REYNOLDS GP
Citation: Cl. Beasley et Gp. Reynolds, SPECIFICITY OF GABAERGIC DEFICITS IN THE FRONTAL-CORTEX IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 89-89
Authors:
REYNOLDS GP
BEASLEY CL
APARICIOLEGARZA MI
QUINT E
Citation: Gp. Reynolds et al., DEFINING AND MODELING THE FRONTAL CORTICAL NEURONAL DEFICITS IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 97-97
Authors:
REYNOLDS GP
BLAKE TJ
TILLERY CE
Citation: Gp. Reynolds et al., ANTIPSYCHOTIC DRUG AFFINITIES FOR THE HUMAN BRAIN ALPHA2 ADRENOCEPTORSUBTYPES, Schizophrenia research, 29(1-2), 1998, pp. 170-171
Authors:
APARICIOLEGARZA MI
DAVIS B
HUTSON PH
REYNOLDS GP
Citation: Mi. Apariciolegarza et al., INCREASED DENSITY OF GLUTAMATE N-METHYL-D-ASPARTATE RECEPTORS IN PUTAMEN FROM SCHIZOPHRENIC-PATIENTS/, Neuroscience letters, 241(2-3), 1998, pp. 143-146
Authors:
MESSMER K
REYNOLDS GP
Citation: K. Messmer et Gp. Reynolds, INCREASED PERIPHERAL BENZODIAZEPINE BINDING-SITES IN THE BRAIN OF PATIENTS WITH HUNTINGTONS-DISEASE, Neuroscience letters, 241(1), 1998, pp. 53-56
Authors:
BLAKE TJ
TILLERY CE
REYNOLDS GP
Citation: Tj. Blake et al., ANTIPSYCHOTIC DRUG AFFINITIES AT ALPHA(2)-ADRENOCEPTOR SUBTYPES IN POSTMORTEM HUMAN BRAIN, J PSYCHOPH, 12(2), 1998, pp. 151-154
Authors:
MESSMER K
REYNOLDS GP
Citation: K. Messmer et Gp. Reynolds, PERIPHERAL-TYPE BENZODIAZEPINE BINDINGS SITES IN HUNTINGTONS-DISEASE, British Journal of Pharmacology, 123, 1998, pp. 203-203
Authors:
APARICIOLEGARZA MI
DAVIS B
REYNOLDS GP
Citation: Mi. Apariciolegarza et al., NMDA RECEPTORS IN THE STRIATUM IN SCHIZOPHRENIA, British Journal of Pharmacology, 123, 1998, pp. 204-204
Authors:
REYNOLDS GP
TILLERY CE
MIDDLEMISS DN
KING RJ
RILEY GJ
STEMP G
Citation: Gp. Reynolds et al., [H-3]NEMONAPRIDE BINDING DEFINES DOPAMINE-D4 RECEPTORS IN RAT RETINALMEMBRANES, British Journal of Pharmacology, 123, 1998, pp. 228-228
Authors:
REYNOLDS GP
SADOCK BJ
Citation: Gp. Reynolds et Bj. Sadock, POCKET HANDBOOK OF PSYCHIATRIC DRUG-TREATMENT, 2ND EDITION - KAPLAN,HI, The American journal of psychiatry, 155(11), 1998, pp. 1621-1621
Authors:
BEASLEY CL
REYNOLDS GP
Citation: Cl. Beasley et Gp. Reynolds, PARVALBUMIN-IMMUNOREACTIVE NEURONS ARE REDUCED IN THE PREFRONTAL CORTEX OF SCHIZOPHRENICS, Schizophrenia research, 24(3), 1997, pp. 349-355
Authors:
REYNOLDS GP
BEASLEY CL
Citation: Gp. Reynolds et Cl. Beasley, PARVALBUMIN-IR NEURONS IN THE FRONTAL-CORTEX IN SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 35-36
Authors:
APARICIOLEGARZA MI
CUTTS AJ
DAVIS B
REYNOLDS GP
Citation: Mi. Apariciolegarza et al., DEFICITS OF [H-3] D-ASPARTATE BINDING TO GLUTAMATE UPTAKE SITES IN STRIATAL AND ACCUMBENS TISSUE IN PATIENTS WITH SCHIZOPHRENIA, Neuroscience letters, 232(1), 1997, pp. 13-16
Authors:
REYNOLDS GP
Citation: Gp. Reynolds, WHAT IS AN ATYPICAL ANTIPSYCHOTIC, J PSYCHOPH, 11(3), 1997, pp. 195-199
Authors:
REYNOLDS GP
Citation: Gp. Reynolds, 5-HT RECEPTORS, GENES AND ANTIPSYCHOTIC MECHANISMS, J PSYCHOPH, 11(1), 1997, pp. 26-27
Authors:
DALTON CF
GIBSON RM
ANDREWS PW
REYNOLDS GP
Citation: Cf. Dalton et al., THE ESTABLISHMENT OF A HUMAN CELL-CULTURE MODEL FOR HUNTINGTONS-DISEASE, Journal of neurochemistry, 69, 1997, pp. 129-129
Authors:
REYNOLDS GP
Citation: Gp. Reynolds, MUSCARINIC M(1) RECEPTORS IN SCHIZOPHRENIA, Molecular psychiatry, 1(5), 1996, pp. 364-365
Authors:
SARDAR AM
CZUDEK C
REYNOLDS GP
Citation: Am. Sardar et al., DOPAMINE DEFICITS IN THE BRAIN - THE NEUROCHEMICAL BASIS OF PARKINSONIAN SYMPTOMS IN AIDS, NeuroReport, 7(4), 1996, pp. 910-912
Authors:
REYNOLDS GP
MASON SL
TILLERY C
Citation: Gp. Reynolds et al., DOPAMINE D4 RECEPTOR ELEVATION IN SCHIZOPHRENIA - FACT OR ARTIFACT, Schizophrenia research, 18(2-3), 1996, pp. 3-3
Authors:
EGGETT CJ
OLEARY TA
REYNOLDS GP
Citation: Cj. Eggett et al., AN IMPROVED MODEL FOR EXAMINING DELAYED EXCITOTOXIC NEURODEGENERATIONIN ISOLATED CHICK RETINA, Neuroscience letters, 219(1), 1996, pp. 65-67
Authors:
REYNOLDS GP
Citation: Gp. Reynolds, DOPAMINE-RECEPTORS AND SCHIZOPHRENIA, Biochemical Society transactions, 24(1), 1996, pp. 202-205
Authors:
REYNOLDS GP
SARDAR AM
Citation: Gp. Reynolds et Am. Sardar, 5-HYDROXYTRYPTAMINE DEFICITS IN THE CAUDATE-NUCLEUS IN AIDS, AIDS, 10(11), 1996, pp. 1303-1304
Authors:
REYNOLDS GP
Citation: Gp. Reynolds, DOPAMINE D4 RECEPTORS IN SCHIZOPHRENIA, Journal of neurochemistry, 66(2), 1996, pp. 881-882